Turns out that ENMD wound up making a deal that provided Celgene with the basis to create and market Revlimid, a blockbuster cancer drug that propelled celgenes stock price and opportunities. ENMD went on trying to bring a particular kinase inhibiter drug through the clinical trial process, and still is. Over the years ENMD stock price was mostly around $1 and less, even less than Nwbo current SP.
A change of management and strategy to address China and American drug opportunities, along with new investors and insider ownership, recently moved CASI (new symbol) from sub dollar to a high in the $8+ area and now back down to around $4+.
This saga took place over more than a decade, and no, I still didn’t sell shares. So it seems I’m drawn to long and painful investments. Like many of the longs in Nwbo I keep holding and adding, to way more than I should have, on the basis of the science, the respected doctors and trial sites, and a belief that LP is in this effort for more than financial gain.
I could be very wrong on all the above however I keep going through the logic and keep betting long. It’s also not all about money since like many others here I have family fighting a cancer and the thought of a well tolerated treatment that might extend lives is such a dream possibility.
For full disclosure I am long Nwbo casi and celgene, but at levels that wouldn’t put my family finances at terrible risk. After all, one shouldn’t risk more than tolerable, imho.
